Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease

Author： Storr Martin   Meining Alexander   Allescher Hans-Dieter  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.7, 2001-07, pp. : 1099-1108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Gastroesophageal Reflux Disease*

By Pettit Michael  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 432-435

Springer Publishing Company

Access to resources Recommend Favorite

Gastroesophageal Reflux Disease in Children with Asthma: Treatment Implications

By Scarupa Mark D.  

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 177-186

Adis International

Access to resources Recommend Favorite

New insights into the treatment of gastroesophageal reflux disease

By Campo Salvatore MA  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1503-1515

Informa Healthcare

Access to resources Recommend Favorite

An Evidence-based Review of Medicinal Herbs for the Treatment of Gastroesophageal Reflux Disease (GERD)

By  

Current Drug Discovery Technologies, Vol. 15, Iss. 4, 2018-12 ,pp. : 305-314

Bentham Science Publishers

Access to resources Recommend Favorite

Gastroesophageal Reflux Disease: Clinical Features*

By Pettit Michael  

Pharmacy World and Science, Vol. 27, Iss. 6, 2005-12 ,pp. : 417-420

Springer Publishing Company

Access to resources Recommend Favorite